Taieb, J., Pernot, S., Thuillier, F., Delattre, A., Petorin, C., Bourgeois, V., Tougeron, D., Audemar, F., Vitellius, C., Laurent, M., Desrame, J., Fiore, F. D., Rinaldi, Y., Pellat, A., Bolliet, M., Watelle, F., Perrier, H., Dubreuil, O., Lepage, C., Bachet, J. (2025). 5-FU + Naliri, gemcitabine plus nab-paclitaxel or both regimens given sequentially for first line treatment of metastatic pancreatic ductal adenocarcinoma: A randomized phase II comparative study (FUNGEMAX-PRODIGE 61).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4184